SEI INVESTMENTS CO

Position in NVAX — Novavax Inc

CIK 350894 OAKS, PA

Position in NVAX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$190,095

+$25,831 QoQ

Shares Held

20,180

0.0% QoQ

Ownership

0.012%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#135

of 263 holders

Holding Since

Jun 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SEI INVESTMENTS CO holds $1,244,722,378 across 210 Biotechnology names. NVAX ranks #164 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	255,073	$236,649,076
2	INSM	INSMED Inc	1,015,870	$108,312,059
3	VRTX	Vertex Pharmaceuticals Inc / Ma	129,981	$64,565,461
4	EXEL	Exelixis, Inc.	1,166,715	$63,480,962
5	ASND	Ascendis Pharma A/S	237,869	$63,444,419
6	INCY	Incyte Corp	498,013	$56,454,752
7	HALO	Halozyme Therapeutics, Inc.	551,116	$43,135,848
8	REGN	Regeneron Pharmaceuticals, Inc.	60,441	$37,687,380

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$190,095	20,180	0.0%	Shares	Sole	2026-08-14
2026-03-31	$164,264	20,180	+0.2%	Shares	Sole	2026-05-13
2025-12-31	$135,387	20,147	0.0%	Shares	Sole	2026-02-13
2025-09-30	$174,673	20,147	0.0%	Shares	Sole	2025-11-13
2025-06-30	$126,925	20,147	0.0%	Shares	Sole	2025-08-14
2025-03-31	$129,141	20,147	+33.8%	Shares	Sole	2025-05-14
2022-03-31	$1,108,579	15,052	-32.2%	Shares	Sole	2022-05-13
2021-12-31	$3,174,150	22,186	-27.7%	Shares	Sole	2022-02-14
2021-09-30	$6,361,929	30,688	+61.7%	Shares	Sole	2021-11-12
2021-06-30	$4,029,006	18,977	-17.0%	Shares	Sole	2021-08-06
2021-03-31	$4,144,927	22,861	+1076.6%	Shares	Sole	2021-05-12
2020-12-31	$216,663	1,943	-45.4%	Shares	Sole	2021-02-08
2020-09-30	$385,400	3,557	-70.8%	Shares	Defined	2020-12-04
2020-06-30	$1,014,618	12,173	—	Shares	Defined	2020-08-17
No filing history on record for this holder in this stock.